CompuMed logo

CompuMed(OTC) CMPD

Market Cap$8.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1990)+27%
5 Year-24%
1 Year+42%
1 Month-8%
$6.33
-2.54%
-0.16Today
CompuMed last closing stock price
MetricPriceDate
Last closeUSD 6.332026-10-08
CompuMed stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.55%USD 6.432026-09-30
1 month-8.26%USD 6.902026-09-08
3 month-5.1%USD 6.672026-07-09
Year to date+43.62%USD 4.412025-12-31
1 year+41.93%USD 4.462025-10-07
3 year+118.28%USD 2.902023-10-06
5 year-23.6%USD 8.292021-10-08
Since inception+26.6%USD 5.001990-08-21

CompuMed Financials at a Glance

Market Cap

$8.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$8.32M

Net Income (TTM)

-$279.51K

EPS (TTM)

-$0.21

P/E Ratio

-29.51

Dividend

$0.00

Beta (Volatility)

0.30 (Low)

Price

$6.33

Volume

90

Open

$6.39

Previous Close

$6.33

Daily Range

$6.33 - $6.42

52-Week Range

$2.67 - $7.87

Estimated Earnings Date

Feb 9, 2026

CMPD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CompuMed

CompuMed, Inc. is a provider of advanced telemedicine solutions, focusing on telecardiology and teleradiology services. The company connects healthcare institutions with U.S. Board-Certified specialists through cloud-based platforms, enhancing clinical care for patients globally.

Products and Services
  • Telecardiology services including ECG, echocardiograms, and vascular studies
  • Teleradiology services offering expert image analysis and reporting
  • OsteoGram software for osteoporosis management and mobile ECG solutions
Growth Outlook
  • Recent quarterly revenue increased to $2.16 million, reflecting a positive trend
  • Gross profit margin improved to 49.5% in the latest quarter
  • Strong cash flow from operations of $422,866 indicates operational efficiency
Financial Highlights
  • Market capitalization stands at approximately $8.71 million
  • Trailing twelve-month revenue of $8.4 million shows consistent performance
  • Current ratio of 2.23 suggests strong liquidity position
CompuMed, Inc. operates in the healthcare information services sector, providing essential telemedicine solutions that cater to a diverse clientele, including rural healthcare providers and correctional facilities. The company's focus on telecardiology and teleradiology positions it well within the growing telehealth market, which has seen increased demand due to advancements in technology and changing healthcare needs. The recent financial performance indicates a positive trajectory, with a notable increase in quarterly revenue and an improved gross profit margin. The strong cash flow from operations further underscores the company's ability to manage its resources effectively. With a solid liquidity position, CompuMed is well-equipped to navigate the evolving healthcare landscape and capitalize on future growth opportunities.
AI Generated • Sep 16, 2026

Industry

Health Care Technology

CEO

Lee D. Keddie

Headquarters

Los Angeles, CA 90045, US

CMPD Financials

Key Financial Metrics (TTM)

Gross Margin

48.15%

Operating Margin

-2.95%

Net Income Margin

-3.36%

Return on Equity

-9.16%

Return on Capital

-0.44%

Return on Assets

-5.84%

Earnings Yield

-3.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.33M

Volume

90

Avg. Volume

1.25K

Financials (TTM)

Gross Profit

$4.00M

Operating Income

-$245.69K

EBITDA

$563.50K

Operating Cash Flow

$546.91K

Capital Expenditure

-$25.00K

Free Cash Flow

$521.91K

Cash & ST Invst.

$1.84M

Total Debt

$545.83K

CompuMed Performance Analysis

CompuMed annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30USD 6,365,264N/A
20232023-09-30USD 5,838,109-8.3%
20242024-09-30USD 6,222,0186.6%
20252025-09-30USD 7,546,20121.3%
CompuMed sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-302.2%
Q12025-12-313.5%
Q22026-03-31-3.2%
Q32026-06-306.2%
CompuMed annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30USD 0.30N/A
20232023-09-30USD -0.02N/A
20242024-09-30USD 0.15N/A
20252025-09-30USD -0.05N/A
CompuMed sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-494.7%
Q12025-12-3186.8%
Q22026-03-31-225.3%
Q32026-06-30129.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$2.16M

+8.7%

Gross Profit

$1.07M

+12.4%

Gross Margin

49.53%

N/A

Market Cap

$8.42MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.05M

N/A

Employees

8

N/A

Net Income

$24.73K

-50.8%

EBITDA

$213.33K

-18.0%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$1.84M

+10.3%

Total Debt

$545.83K

-29.6%

Accounts Receivable

$1.06M

-3.6%

Inventory

$154.77K

+508.1%

Long Term Debt

$302.93K

-44.5%

Short Term Debt

$242.90K

+6.0%

Return on Assets

-5.84%

N/A

Return on Invested Capital

-7.38%

N/A

Free Cash Flow

$422.87K

+33.2%

Operating Cash Flow

$422.87K

-38.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HLYKHealthLynked Corp.
$2.25+0.00%
TDSGFTelo Genomics Corp.
$0.05+42.86%
RSCFReflect Scientific, Inc.
$0.05+0.00%
TGIFF1933 Industries Inc.
$0.01-20.93%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$33.79+10.24%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$142.52-10.31%
TQQQProShares Trust - ProShares UltraPro Qqq
$80.23-4.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$33.37+4.05%

Questions About CMPD

What is the current price of CompuMed?

CompuMed is trading at $6.33 per share.

What is the 52-week range for CompuMed?

Over the past 52 weeks, CompuMed has traded between $2.67 and $7.87.

How much debt does CompuMed have?

As of the most recent reporting period, CompuMed reported total debt of $545.83K.

How much cash does CompuMed have on hand?

CompuMed reported $1.84M in cash and cash equivalents in its most recent financial results.

What is CompuMed’s dividend yield?

CompuMed does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.